Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D.
About this episode
Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating conditions associated with these antibodies.
(00:32)
Could you please give our listeners an overview of your role at Mayo Clinic?
(01:22)
What updates are happening in our laboratory to increase specificity when we receive a patient's serum and CSF for most of the CNS evaluations?
(03:48)
Why are these updates and additions important in the larger disease state?
(06:16)
Could you expound upon the relationship between the clinical practice and the lab?
(08:32)
What do these changes mean for patient care?
(10:27)
What about the inclusion of AMPA in the pediatric evaluation, and the inclusion of IgLON5 with autoimmune axonal?
(12:58)
How does your lab discern when it's time to add a biomarker?
(15:44)
What are you most excited about?
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab
Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab
Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab
Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab
Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab